Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The tendon-relevant mechanism operates through actin-dependent cell migration and endothelial cell recruitment
BPC-157s regenerative properties also extend to joint health, making it a potential therapeutic option for conditions like arthritis
Professor Muresanus research contributions include: Principal investigator for the CARS trial (Cerebrolysin and Recovery After Stroke), the largest randomized controlled trial examining functional outcomes Lead investigator for CAPTAIN trials evaluating Cerebrolysin in traumatic brain injury populations Extensive research on neurotrophic factor signaling and neuroprotective mechanisms Development of multimodal therapeutic strategies combining Cerebrolysin with rehabilitation Investigations of dose-response relationships and optimal treatment protocols across neurological conditions His work has been instrumental in advancing understanding of peptidergic neuroprotection, though clinical translation challenges remain a focus of ongoing investigation
The most commonly used medication in this treatment is alprostadil, a synthetic version of prostaglandin E1 (PGE1)
US$ 26.09
US$ 20.83
US$ 26.70
US$ 24.01
US$ 20.93
US$ 29.42
US$ 22.34
US$ 21.57
